Irevia Trademark Details
Word Mark | Irevia |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Accentia Biopharmaceuticals, Inc. of Tampa, FL
View all trademarks for Accentia Biopharmaceuticals, Inc.Serial Number | 85423818 |
---|---|
Status Date | Monday, November 12, 2012 |
Filing Date | Monday, November 12, 2012 |
Attorney | Corey K. Cho |
Correspondent
COREY K. CHO
SALIWANCHIK, LLOYD & EISENSCHENK
PO BOX 142950
GAINESVILLE, FL 32614-2950
SALIWANCHIK, LLOYD & EISENSCHENK
PO BOX 142950
GAINESVILLE, FL 32614-2950
Case File Statements
Goods & Services | Pharmaceutical preparation, comprising intravenously administered cyclophosphamide, a cytotoxic drug, for the purpose of rebooting the immune system in the treatment and prevention of immune disorders |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, September 21, 2011 |
Primary Code | 005 |
Trademark Timeline
-
Sep 15 2011Trademark application filed with USPTO
-
Sep 19 2011New Application Entered In Tram
-
Sep 21 2011New Application Office Supplied Data Entered In Tram
-
Dec 17 2011Assigned To Examiner
-
Dec 19 2011Approved For Pub - Principal Register
-
Jan 09 2012Assigned To Lie
-
Jan 10 2012Law Office Publication Review Completed
-
Jan 25 2012Notification of Notice of Publication E-Mailed
-
Feb 14 2012Official Gazette Publication Confirmation E-Mailed
-
Feb 14 2012Published For Opposition
-
Apr 10 2012Noa E-Mailed - Sou Required From Applicant
-
Nov 12 2012Abandonment - No Use Statement Filed
-
Nov 13 2012Abandonment Notice Mailed - No Use Statement Filed